A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
NCT03224598
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatosis Papulosa Nigra
Interventions
DRUG:
A-101 Topical Solution 40%
Sponsor
Aclaris Therapeutics, Inc.